Baker Bros. Advisors (GP) LLC, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 390,080 shares at $76.15 ($29.6M) on 2018-12-07, disclosed to the SEC on 2018-12-07.
Open-market sale of $29.6M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.46 | 89 | $7K | 0.0% |
| 2 | $75.46 | 1,172 | $88K | 0.3% |
| 3 | $75.46 | 1,172 | $88K | 0.3% |
| 4 | $75.46 | 1,309 | $99K | 0.3% |
| 5 | $75.46 | 1,309 | $99K | 0.3% |
| 6 | $75.46 | 2,021 |
| $153K |
| 0.5% |
| 7 | $75.46 | 2,021 | $153K | 0.5% |
| 8 | $75.46 | 11,724 | $885K | 3.0% |
| 9 | $75.46 | 11,724 | $885K | 3.0% |
| 10 | $75.46 | 76,364 | $5.8M | 19.5% |
| 11 | $75.46 | 76,364 | $5.8M | 19.5% |
| 12 | $76.15 | 99 | $8K | 0.0% |
| 13 | $76.15 | 1,296 | $99K | 0.3% |
| 14 | $76.15 | 1,296 | $99K | 0.3% |
| 15 | $76.15 | 1,447 | $110K | 0.4% |
| 16 | $76.15 | 1,447 | $110K | 0.4% |
| 17 | $76.15 | 2,234 | $170K | 0.6% |
| 18 | $76.15 | 2,234 | $170K | 0.6% |
| 19 | $76.15 | 12,961 | $987K | 3.3% |
| 20 | $76.15 | 12,961 | $987K | 3.3% |
| 21 | $76.15 | 84,418 | $6.4M | 21.7% |
| 22 | $76.15 | 84,418 | $6.4M | 21.7% |
| Total | $75.82 avg | 390,080 | $29.6M | 100% |
| Filing → |
| KOD | BUY | 2026-09-30 | $63.4M | — | Filing → |
| TRDA | BUY | 2025-11-12 | $2.6M | — | Filing → |
| CELC | BUY | 2025-09-10 | $19.1M | — | Filing → |